Corient Private Wealth’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$700K Buy
26,430
+13,214
+100% +$350K ﹤0.01% 1607
2025
Q1
$319K Buy
13,216
+797
+6% +$19.2K ﹤0.01% 1815
2024
Q4
$500K Sell
12,419
-396
-3% -$15.9K ﹤0.01% 1617
2024
Q3
$811K Buy
12,815
+486
+4% +$30.8K ﹤0.01% 1482
2024
Q2
$654K Sell
12,329
-9,971
-45% -$529K ﹤0.01% 1502
2024
Q1
$1.83M Buy
22,300
+828
+4% +$67.9K ﹤0.01% 1059
2023
Q4
$400K Buy
+21,472
New +$400K ﹤0.01% 1725